Erison Tablets (Eperisone Hydrochloride)

Adult dose

For adults: 50 mg of eperisone hydrochloride should be taken orally three times a day after meals. Dose can be adjusted according to age and symptoms.

This medication should not be used in certain patients. First, individuals who have had an allergic reaction to this medication should not take it. Additionally, this medication should not be used in patients with myasthenia gravis who have very weak muscles. This medication contains lactose, so people with genetic disorders who cannot digest lactose should also avoid it. Some patients should use this medication with caution. Those with a history of drug allergies should be administered this medication carefully. Patients with liver dysfunction should exercise caution as liver function may deteriorate further. Rarely, a severe allergic reaction referred to as shock may occur; if symptoms arise, the medication should be stopped immediately and appropriate treatment should be sought. Liver function test values may rise, so if unusual symptoms occur, the medication should be discontinued, and consultation with a doctor is necessary. It may also affect kidney function, so caution is needed if there is proteinuria or abnormal blood test results. Blood abnormalities, such as anemia, may also rarely occur, requiring observation. Skin rashes or itching may occur, and psychological symptoms such as insomnia, drowsiness, headache, and paresthesia may manifest. Gastrointestinal symptoms can include nausea, vomiting, decreased appetite, abdominal pain, and diarrhea. Urological symptoms can include difficulty urinating or a feeling of incomplete bladder emptying. Systemic symptoms such as lethargy, dizziness, and decreased muscle tension may occur. Redness of the face or excessive sweating may also be noted. Severe skin reactions, such as toxic epidermal necrolysis or Stevens-Johnson syndrome, may occur; if fever, skin rashes, blisters, itching, eye congestion, or oral inflammation occur, the medication should be stopped immediately and the patient should go to the hospital. Drowsiness or decreased concentration may occur while taking this medication, so it is advisable to avoid driving or operating dangerous machinery. Caution is necessary if this medication is used together with similar medications as visual disturbances can occur. Women who are pregnant or may become pregnant should take this medication only when the benefits of treatment are deemed greater than the risks. Breastfeeding women should avoid this medication if possible, and if it must be taken, it is advisable to stop breastfeeding. Safety in children has not been sufficiently established, so caution is needed when using it in this population. Elderly patients may experience diminished physical function, so they should use this medication carefully, such as by reducing the dosage.

Serious side effects

Shock, anaphylactic reaction, angioedema, toxic epidermal necrolysis, and mucocutaneous eye syndrome (Stevens-Johnson syndrome), liver dysfunction (increased ALT, AST, ALP), kidney dysfunction (proteinuria, increased BUN), anemia, severe allergic reactions, severe skin reactions

Mild side effects

• Occasional rash
• itching
• insomnia
• drowsiness
• headache
• rigidity of the body
• limb tremors
• nausea
• vomiting
• decreased appetite

This medication should be stored in a tightly closed container to prevent air from entering and should be kept at room temperature between 1 to 30 degrees Celsius. Storing it this way helps maintain the medication's efficacy and prevents deterioration.

Appearance

Domestic use: white round film-coated tablets Export use: white round film-coated tablets

Package unit

Domestic use: 30 tablets/bottle, 500 tablets/bottle Export use: 30 tablets (10 tablets/PTP*3), 100 tablets (10 tablets/PTP*10)